Literature DB >> 24765354

Simultaneous chickenpox and measles infection among migrant children who stayed in Italy during the second half of June 2011.

Igor Ivić-Hofman1, Ante Cvitković1, Bernard Kaić2, Tatjana Vilibić-Čavlek3, Nenad Pandak4, Zorana Marić1, Dragana Jurić1.   

Abstract

We are reporting on a household outbreak of measles, in which cases of simultaneous measles and chickenpox infection occured in children of a family who resided in Italy during the incubation period (June 2011). In three children, fever and generalized confluent macular rash were the dominant symptoms. Serology testing revealed simultaneous measles and chickenpox infection in four children.

Entities:  

Keywords:  measles infection.; simultaneous chickenpox

Year:  2011        PMID: 24765354      PMCID: PMC3981447          DOI: 10.4081/cp.2011.e113

Source DB:  PubMed          Journal:  Clin Pract        ISSN: 2039-7275


Introduction

Measles and chickenpox are two separate clinical entities. They are caused by distinct viruses that belong to different families (varicella-zoster virus, a DNA virus belonging to the family Herpesviridae; morbilli virus, an RNA virus belonging to the family Paramyxoviridae).[1] Universal measles vaccination was introduced into the Croatian Immunization Program in 1968. Owing to sustained high vaccination coverage with two doses of measles vaccine, at the age of one and seven years, measles are virtually eliminated in Croatia.[2] In the last decade only sporadic imported cases of measles are reported, with the exception of two small outbreaks, which occured in 2004 and 2008 following importation of measles.[3] Since there is no universal chickenpox vaccination in Croatia and the number of vaccinated persons upon request is very low, chickenpox is a common childhood disease with an annual incidence of 25–30 cases per 1000 children under 15 years of age.[4]

Case Report

A migrant family resided in Italy in the second half of June 2011. The first symptoms of illness (fever and rash on the trunk and extremities) appeared during their stay in Italy. Upon arrival to Croatia, on 5 July, two of the children (15 and eight years of age) were admitted to hospital with suspected measles and chickenpox. Both children presented with fever up to 39°C, dry cough and confluent macular rash wich was most prominent on the face and neck. The 15-year-old daughter had prominent retroauricular confluent rash and Koplik spots on the buccal mucosa. Five days later, on 10 July an 18-year-old boy from the same family, presented at the infectology clinic with fever up to 39°C and dense confluent macular rash, with numerous scabs on the face and entire body. An epidemiological investigation revealed that he had chickenpox with disease onset at the time of their stay in Italy about 15 June. The epidemiological investigation focused on ten children from the same family. In six children (including the two hospitalized girls) blood samples were taken on 14 July and sent to the Refence Laboratory at the Croatian National Institute of Public Health (CNIPH) for measles and varicella-zoster serology testing. Based on clinical manifestations and results of serology testing, four of these six children had simultaneous infection with measles and varicella and two children had chickenpox. Four siblings who had no symptoms and had no history of measles immunization were vaccinated with a monovalent measles vaccine following the investigation.

Laboratory Investigation

Serologic tests were performed at WHO National Measles Laboratory, Department of Virology (CNIPH). Specific IgM and IgG antibodies to measles and varicella-zoster virus (VZV) were detected using commercial enzyme-linked immunosorbent assay (Virotech, Russelsheim, Germany). VZV IgG positive samples were tested for IgG avidity (Euroimmun, Lubeck, Germany). Serologic results are presented in Table 1. In two patients (patiens 1 and 2) varicella infection was confirmed by presence of IgM antibodies and low IgG avidity. Four patients (patients 3–6) showed simultaneous measles and varicella infection. All of them had positive measles IgM antibodies. Two patients (patients 3 and 4) had positive VZV IgM antibodies with low IgG avidity. For two patients (patients 5 and 6), paired samples were obtained three weeks later. In both patients, varicella infection was confirmed by low IgG avidity in the second sample (Table 1).
Table 1

Serologic results in six patients with suspected measles and varicella infection.

PatientAgeSexMeasles virusVaricella-zoster virus
IgMIgGIgMIgGIgG avidity
1I11FNegativeNegativePositivePositiveLow
2I12MNegativeNegativePositivePositiveLow
3I15FPositiveNegativeNegativePositiveLow
4I8FPositiveNegativePositivePositiveLow
5I18MPositiveNegativePositiveEquivocal-
II*PositivePositivePositivePositiveLow
6I12FPositivePositiveNegativeNegative-
II*PositivePositivePositiveEquivocalLow

Paired serum samples (obtained three weeks later).

Paired serum samples (obtained three weeks later).

Discussion

The epidemiological investigation revealed that none of the ten children were vaccinated against measles (which is mandatory according to the Childhood Immunization Programme in Croatia) or varicella (which is not mandatory). The fact that none of the children were vaccinated represents a public health issue in a relatively small migrant population and indicates that vaccination coverage may be low in this population. Simultaneous infection and clinical illnesses of a viral and bacterial etiology is a well known fact, as well as co-infections but not simultaneous illness caused by two distinct viruses. However, clinical disease caused by two viruses at the same time is known to be a feature of only a few viruses, notably HIV, hepatitis B and hepatitis C viruses. Our literature search revealed only a few case report of children who had measles and chickenpox at the same time.[5-8] All these cases occurred at the time when incidences of both measles and chickenpox were high in the populations. Due to very high incidence rates of chickenpox and still high incidence of measles in countries with low vaccination coverage, one would expect numerous cases of simultaneous disease in the absence of some kind of immunological interference. The rarity of reports on simultaneous measles and chickenpox illness indicates that recent infection with one virus results in suppression of clinically manifest disease caused by another virus if a person acquires the other infection soon afterward.[9,10] The simultaneous illness described in our report is quite unexpected because measles is virtually eliminated in Croatia and in earlier decades, when measles was a common childhood disease, we have not identified cases of simultaneous clinical illness caused by measles and chickenpox.
  6 in total

1.  Immunity to measles in the Croatian population.

Authors:  Berislav Borcić; Renata Mazuran; Bernard Kaić
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  INHIBITION OF MEASLES RASH BY CHICKENPOX.

Authors:  V KNIGHT; W F FLEET; D J LANG
Journal:  JAMA       Date:  1964-05-18       Impact factor: 56.272

3.  Inhibition of chickenpox lesions by measles and measles rash by chickenpox.

Authors:  V Knight
Journal:  JAMA       Date:  1973-03-05       Impact factor: 56.272

4.  Fatal measles pneumonia in a child with chickenpox pneumonia.

Authors:  L A Lobes; J D Cherry
Journal:  JAMA       Date:  1973-03-05       Impact factor: 56.272

5.  Modified skin lesions during concurrent varicella and measles infections.

Authors:  T C Merigan; D Waddell; M Grossman; J H Ritchie; G Mo
Journal:  JAMA       Date:  1968-04-22       Impact factor: 56.272

6.  Simultaneous infection of measles and varicella-zoster virus in a child in India.

Authors:  Dipankar Biswas; Kaushal Yadav; Biswajyoti Borkakoty; Jagadish Mahanta
Journal:  J Med Virol       Date:  2011-11       Impact factor: 2.327

  6 in total
  1 in total

1.  Chickenpox and measles clusters among college students in Pune, Maharashtra.

Authors:  Avinash R Deoshatwar; Vijay P Bondre; Babasaheb V Tandale
Journal:  Virusdisease       Date:  2017-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.